The Race Against Time for the Enhancement of African National Strategic Plans in the Neuroblastoma Research Heterogeneity

Mmei Cheryl Motshudi (), Clarissa Marcelle Naidoo and Nqobile Monate Mkolo
Additional contact information
Mmei Cheryl Motshudi: Department of Biology, School of Science and Technology, Sefako Makgatho Health Science University, Pretoria 0204, South Africa
Clarissa Marcelle Naidoo: Department of Biology, School of Science and Technology, Sefako Makgatho Health Science University, Pretoria 0204, South Africa
Nqobile Monate Mkolo: Department of Biology, School of Science and Technology, Sefako Makgatho Health Science University, Pretoria 0204, South Africa

Publications, 2024, vol. 12, issue 4, 1-21

Abstract: The valuation of neuroblastoma research heterogeneity at African country level is unspecified. Therefore, the study assesses the heterogeneity of neuroblastoma research in 54 African countries and develops recommendations for national cancer-control plans. Metadata of peer-reviewed scientific publications allied to African neuroblastoma research were retrieved from the Web of Science™ Core Collection Database for bibliometric analysis. Comprehensive science mapping analysis and statistical analyses were performed with bibliometric online platform 2 and GraphPad Prism v. 10.2.3. This study revealed that African countries focused the neuroblastoma research publications mainly on the sustainable development goal of good health and well-being. The dominating research area in Africa is oncology followed by pharmacology. Only 26 of 54 African countries were accountable for total neuroblastoma research in Africa, with South Africa and Egypt contributing 61% of the whole continent’s neuroblastoma research. Egypt, South Africa, Tunisia, Morocco, and Nigeria are the five most active African countries, and they are funded by different funding agencies internationally and domestically. The collected analysed data of this study draws special attention to heterogeneity and enduring upward correlating trajectory of Africa’s neuroblastoma publication numbers, their citations, acquired funds, and countries’ cooperation. Furthermore, this heterogeneity finding flags the necessity of developing a comprehensive strategic plan and implementation to cultivate neuroblastoma research as a fundamental part of each African country’s national cancer control plans.

Keywords: cancer; neuroblastoma research; Africa; heterogeneity; bibliometric analysis (search for similar items in EconPapers)
JEL-codes: A2 D83 L82 (search for similar items in EconPapers)
Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/2304-6775/12/4/45/pdf (application/pdf)
https://www.mdpi.com/2304-6775/12/4/45/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jpubli:v:12:y:2024:i:4:p:45-:d:1535442

Access Statistics for this article

Publications is currently edited by Ms. Jennifer Zhang

More articles in Publications from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().